Diffusion tensor imaging in multiple sclerosis at different final outcomes
Andersen, O., Hildeman, A., Longfils, M., Tedeholm, H., Skoog, B., Tian, W., Zhong, J., Ekholm, S., Novakova, L., Runmarker, B., Nerman, O., Maier, S. E.
Published in Acta neurologica Scandinavica (01.02.2018)
Published in Acta neurologica Scandinavica (01.02.2018)
Get full text
Journal Article
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs
Tedeholm, H, Lycke, J, Skoog, B, Lisovskaja, V, Hillert, J, Dahle, C, Fagius, J, Fredrikson, S, Landtblom, A-M, Malmeström, C, Martin, C, Piehl, F, Runmarker, B, Stawiarz, L, Vrethem, M, Nerman, O, Andersen, O
Published in Multiple sclerosis (01.05.2013)
Published in Multiple sclerosis (01.05.2013)
Get full text
Journal Article
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis
Tedeholm, H, Piehl, F, Lycke, J, Link, J, Stawiarz, L, Burman, J, de Flon, P, Fink, K, Gunnarsson, M, Mellergård, J, Nilsson, P, Sundström, P, Svenningsson, A, Johansson, H, Andersen, O
Published in Multiple sclerosis and related disorders (2022)
Published in Multiple sclerosis and related disorders (2022)
Get full text
Journal Article
Short-term prediction of secondary progression in a sliding window: A test of a predicting algorithm in a validation cohort
Skoog, B, Link, J, Tedeholm, H, Longfils, M, Nerman, O, Fagius, J, Andersen, O
Published in Multiple sclerosis journal - experimental, translational and clinical (01.07.2019)
Published in Multiple sclerosis journal - experimental, translational and clinical (01.07.2019)
Get full text
Journal Article
Factors determining the risk of conversion to secondary progressive multiple sclerosis
Tedeholm, H., Skoog, B., Runmarker, B., Odén, Anders, Andersen, O.
Published in 29th Congress of The European Committee for Treatment and Research in Multiple Sclerosis. 2-5 oktober, Köpenhamn. Multiple Sclerosis Journal (2013)
Get full text
Published in 29th Congress of The European Committee for Treatment and Research in Multiple Sclerosis. 2-5 oktober, Köpenhamn. Multiple Sclerosis Journal (2013)
Conference Proceeding
Current immunotherapy in relapsing-remitting MS reduces the risk of transition to secondary progression. A 10-year study using virtual placebo technique based on hazard functions
Tedeholm, H, Skoog, B, Hillert, J, Runmarker, B, Stawiarz, L, Anderson, O
Published in EUROPEAN JOURNAL OF NEUROLOGY (2008)
Get full text
Published in EUROPEAN JOURNAL OF NEUROLOGY (2008)
Conference Proceeding